Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca10e34ed379358f5c43c04ab6b889a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_234db831cfc4857b59f55b3065e858e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d50bc4df51f8d9514178da82fe49ca58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b04b07294180189ec67ae3f2d1a32588 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c1ee2f73701227f2ea1bef9caf3a315 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-6615 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65746 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-6615 |
filingDate |
2011-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbc2417a9985be5c75fb88f33ece2fb0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61bf8af5f036e940a8cbf9e1f66f902d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbbe4799896b4cd121632b2eac8629fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c85b36be0da817a715f7dd78234aa78 |
publicationDate |
2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2012010174-A1 |
titleOfInvention |
Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin |
abstract |
The present invention relates to mixed calcium/sodium salt of inositol tripyrophosphate, methods of preparing and methods of use. The mixed calcium/sodium salt may be a monocalcium tetrasodium salt of inositol tripyrophosphate. Methods of use include administering the above salts in an effective amount to treat diseases caused by hypoxia or other conditions associated with inadequate function of the lungs or circulatory system, such as various types of cancer and Alzheimer's disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10808661-B2 |
priorityDate |
2004-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |